1-34900163-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001080418.3(DLGAP3):c.1218C>T(p.Ser406Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000774 in 1,613,976 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0010 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00075 ( 8 hom. )
Consequence
DLGAP3
NM_001080418.3 synonymous
NM_001080418.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0210
Publications
1 publications found
Genes affected
DLGAP3 (HGNC:30368): (DLG associated protein 3) Predicted to enable PDZ domain binding activity; molecular adaptor activity; and scaffold protein binding activity. Predicted to be involved in protein-containing complex assembly and regulation of postsynaptic neurotransmitter receptor activity. Predicted to be located in synapse. Predicted to be part of postsynaptic density. Predicted to be active in several cellular components, including cholinergic synapse; glutamatergic synapse; and neuromuscular junction. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 1-34900163-G-A is Benign according to our data. Variant chr1-34900163-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 724007.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.021 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 8 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLGAP3 | NM_001080418.3 | c.1218C>T | p.Ser406Ser | synonymous_variant | Exon 4 of 12 | ENST00000373347.6 | NP_001073887.1 | |
DLGAP3 | XM_011541879.3 | c.1218C>T | p.Ser406Ser | synonymous_variant | Exon 5 of 13 | XP_011540181.1 | ||
DLGAP3 | XM_047426631.1 | c.1218C>T | p.Ser406Ser | synonymous_variant | Exon 4 of 12 | XP_047282587.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLGAP3 | ENST00000373347.6 | c.1218C>T | p.Ser406Ser | synonymous_variant | Exon 4 of 12 | 5 | NM_001080418.3 | ENSP00000362444.1 | ||
DLGAP3 | ENST00000235180.4 | c.1218C>T | p.Ser406Ser | synonymous_variant | Exon 2 of 10 | 2 | ENSP00000235180.4 |
Frequencies
GnomAD3 genomes AF: 0.00101 AC: 154AN: 152172Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
154
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00133 AC: 334AN: 251350 AF XY: 0.00133 show subpopulations
GnomAD2 exomes
AF:
AC:
334
AN:
251350
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000749 AC: 1095AN: 1461686Hom.: 8 Cov.: 32 AF XY: 0.000773 AC XY: 562AN XY: 727152 show subpopulations
GnomAD4 exome
AF:
AC:
1095
AN:
1461686
Hom.:
Cov.:
32
AF XY:
AC XY:
562
AN XY:
727152
show subpopulations
African (AFR)
AF:
AC:
2
AN:
33478
American (AMR)
AF:
AC:
13
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
710
AN:
26136
East Asian (EAS)
AF:
AC:
2
AN:
39700
South Asian (SAS)
AF:
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
53240
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
242
AN:
1111988
Other (OTH)
AF:
AC:
124
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
76
153
229
306
382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00101 AC: 154AN: 152290Hom.: 1 Cov.: 32 AF XY: 0.000953 AC XY: 71AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
154
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
71
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41572
American (AMR)
AF:
AC:
5
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
123
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5168
South Asian (SAS)
AF:
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20
AN:
68022
Other (OTH)
AF:
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 16, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
DLGAP3: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.